Journal for ImmunoTherapy of Cancer (Nov 2020)
30 NLR (neutrophil lymphocyte ratio) and PLR (platelet lymphocyte ratio) changes as a predictor of eventual treatment failure and death on nivolumab therapy in renal cell carcinoma
Abstract
No abstracts available.